Anti-β2GP1 antibodies have variable effects on platelet aggregation

Pathology

Volumn 45, Issue 2, 2013, Pages 155-161

  Betts, Natasha A ^a   Ahuja, Kiran D K ^a   Adams, Murray J ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anti phospholipid antibody; Platelet aggregation; Platelets; Thrombosis

Indexed keywords

EID: 84873861935     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32835cc277     Document Type: Article

References (24)

1. Pierangeli SS, Liu SW, Anderson G, et al. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation 1996; 94: 1746-51.
2. Espinosa G, Cervera R. Morbidity and mortality in the antiphospholipid syndrome. Curr Opin Pulm Med 2009; 15: 413-7.
3. Palatinus A, Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost 2009; 35: 621-9.
4. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2003; 101: 157-62.
5. Arvieux J, Roussel B, Pouzol P, et al. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I. Thromb Haemost 1993; 70: 336-41.
6. Palatinus AA, Ahuja KD, Adams MJ. Effects of antiphospholipid antibodies on in vitro platelet aggregation. Clin Appl Thromb Hemost 2012; 18: 59-65.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
8. Ahuja KD, Adams MJ, Robertson IK, et al. Acute effect of a highcarbohydrate low-fat meal on platelet aggregation. Platelets 2009; 20: 606-9.
9. Ahuja KD, Thomas GA, Adams MJ, et al. Postprandial platelet aggregation: effects of different meals and glycemic index. Eur J Clin Nutr 2012; 66: 722-6.
10. Adams M, Breckler L, Stevens P, et al. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Haematologica 2004; 89: 985-90.
11. Adams MJ, Palatinus AA, Harvey AM, et al. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus. Lupus 2011; 20: 1474-83.
12. Lean SY, Ellery P, Ivey L, et al. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. Haematologica 2006; 91: 1360-6.
13. Puri RN. Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms. Int J Biochem Cell Biol 1998; 30: 1107-22.
14. Hechler B, Leon C, Vial C, et al. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood 1998; 92: 152-9.
15. Lutters BC, Derksen RH, Tekelenburg WL, et al. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem 2003; 278: 33831-8.
16. Kouts S,Wang MX, Adelstein S, et al. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune antiphospholipid antibodies. J Immunol 1995; 155: 958-66.
17. Blank M, Faden D, Tincani A, et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 441-55.
18. Pierangeli SS, Harris EN. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol 1993; 93: 269-72.
19. George J, Blank M, Gilburd B, et al. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I. Int Immunol 1997; 9: 913-21.
20. de Laat B, Derksen RH, de Groot PG. High-avidity anti-beta glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-beta glycoprotein I antibodies. J Thromb Haemost 2006; 4: 1619-21.
21. de Laat B, Derksen RH, Urbanus RT, et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105: 1540-5.
22. de Prost D, Ollivier V, Ternisien C, et al. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus. Thromb Haemost 1990; 64: 216-21.
23. Martini F, Farsi A, Gori AM, et al. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus. Lupus 1996; 5: 206-11.
24. Galli M, Ruggeri L, Barbui T. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 1998; 91: 1999-2004.